Surgery Websites
Transplant Surgery »  Meet the Team »  Pediatric Gastroenterology »  Melvin B. Heyman, M.D., M.P.H.
Melvin B. Heyman, M.D., M.P.H.

Melvin B. Heyman, M.D., M.P.H.

  • Professor of Pediatrics Chief, Division of Pediatric Gastroenterology, Hepatology and Nutrition Department of Pediatrics Director, Pediatric Inflammatory Bowel Disease Program
Open Popup

UCLA School of Medicine 1976

  • LAC/USC Medical Center, Pediatrics 1979
  • UCLA Medical Center, Gastroenterology and Nutrition 1981
  • American Board of Pediatrics, General Pediatrics, Pediatric Gastroenterology Subspecialty

Dr. Melvin B. Heyman, chief of pediatric gastroenterology, hepatology and nutrition at UCSF Benioff Children's Hospital, specializes in treating children with inflammatory bowel disease, including Crohn's disease and ulcerative colitis, and nutrition-related problems. He earned a medical degree at UCLA and completed a pediatric residency at Los Angeles County-University of Southern California Medical Center. He also completed postdoctoral training in nutrition, earned a master's degree in public health, and completed a fellowship in pediatric gastroenterology at UCLA. In 1981, he joined UCSF, where he organized the pediatric nutrition support service and established protocols for pediatric gastroenterology.

A UCSF professor of pediatrics, Dr. Heyman is chair of the executive committee of the Pediatric Gastroenterology and Nutrition section of the American Academy of Pediatrics. He also serves on many local and national committees, including the American Academy of Pediatrics' Task Force on Prevention of Obesity in School Health (POSH),  and the National Board of the National PTA. Dr. Heyman has an active role in teaching at all levels. He is the principal investigator for the NIH Training Grant that funds the Training Program in Pediatric Gastroenterology and Nutrition at UCSF.

Dr. Heyman's research has been oriented towards clinical problems in pediatric patients with nutrition and/or gastroenterologic issues. He was one of the first investigators to reveal the importance of nutrition support in sickle cell anemia, helped to develop procedures in the diagnosis of hepatobiliary problems in infants, and has been actively pursuing novel treatments for children with inflammatory bowel disease and gastroesophageal reflux disease.

His research has been funded by the NIH, by foundation grants, and by pharmaceutical and formula industry support.  His recent research has been evolving into investigation of obesity in infancy and in school age children.  With other members of COAST, he is looking at the effects of acculturation in the Latino and the Chinese populations in San Francisco.  He is also very actively involved in developing strategies to improve nutrition and physical activities in public schools.

Data provided by UCSF Profiles, powered by CTSI
  • Training Program in Pediatric Gastroenterology/Nutrition
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 1998
    -
    Jun 2018
    Principal Investigator
  • Studies in Children with Digestive Disorders
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 2002
    -
    Jun 2013
    Principal Investigator
  • Pathologic Markers of Genetic Damage and Disease in IBD
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2004
    -
    Jul 2008
    Principal Investigator
  • PEDIATRIC CLINICAL RESEARCH CENTER
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 1981
    -
    Mar 2007
    Co-Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 333
Data provided by UCSF Profiles, powered by CTSI
  1. Cuneo AA, Outram S, Marsac ML, Vendlinski S, Heyman MB, Ly N, von Scheven E, Perito ER. Medical traumatic stress in cystic fibrosis: A qualitative analysis. J Cyst Fibros. 2023 07; 22(4):763-771. View in PubMed
  2. Patel PV, Kao E, Stekol E, Heyman MB, Vu L, Verstraete SG. Evaluating the Relationship Between Nutrition and Post-colectomy Pouchitis in Pediatric Patients with Ulcerative Colitis. Dig Dis Sci. 2023 06; 68(6):2188-2195. View in PubMed
  3. Verburgt CM, Dunn KA, Otley A, Heyman MB, Verstraete S, Sunseri W, Sylvester F, de Meij T, Comeau A, Langille M, de Jonge WJ, Benninga MA, Van Limbergen JE. Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study. BMJ Open. 2023 02 01; 13(2):e064944. View in PubMed
  4. Cuneo AA, Abu-El-Haija M, Marsac ML, Verstraete S, Heyman MB, Ly N, Perito ER. Pediatric Medical Traumatic Stress in Inflammatory Bowel Disease, Pancreatitis, and Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2022 10 01; 75(4):455-461. View in PubMed
  5. Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol EI. Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):64-69. View in PubMed
  6. View All Publications

 

Site Directory
    X